Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion




RESEARCH|REPORTS
asubmitoticconcentrationisreachedanddivisionceases(26).
Thetwo-stageDDprogrammingmodelmakestwokeypredictionsfortheroleofextrinsicfac-tors,suchasIL-2,thatcouldbetestedduringinvivoCD8+Tcellresponses:(i)themajorphys-iologicalroleofautocrineIL-2isinmaintainingdivision,andthereforeitwillbemoreimportantawayfromtheinitialsiteofCD8+Tcellpriming;and(ii)theeffectofIL-2onDDwillsumwithotherstimuli,allowingthepredictionofCD8+TcellexpansionkineticswhenIL-2andotherstimuliarecombined.
WetestedthefirstpredictionbycomparingtheexpansionofIL-2receptora–deficientOT-ICD8+Tcells(OT-I/Il2ra / )withOT-I/Il2ra+/+CD8+Tcellsintwodifferentinvivosystems,namelyananti-influenzaresponseandisletgraftrejectionmod-el.SimilarnumbersofOT-I/Il2ra+/+andOT-I/Il2ra / CD8+Tcellsweredetectedatthesiteofpriming[mediastinallymphnode(mLN)]duringtheexpansionphasewhencotransferredintoHKx31-N4infectedmice(Fig.4A).Incontrast,abiastowardexpansionofOT-I/Il2ra+/+CD8+Tcellswasobservedinthespleenandlungs,con-sistentwitharoleforIL-2inthemaintenanceofcellexpansion(Fig.4A).OT-I/Il2ra+/+CD8+TcellsalsooutcompetedOT-I/Il2ra / CD8+Tcellsattheeffectorsiteduringananti-isletgraftresponse(Fig.4B).Theproportionofbromodeoxyuridine-positive(BrdU+)OT-I/Il2ra+/+CD8+Tcellsaftera1-hourinvivoBrdUpulsewas~2.5timesashighasforOT-I/Il2ra / CD8+Tcellsinthegraft(Fig.4C),confirmingthatthisbiaswasattribut-abletoproliferationintheeffectorsiteandnotduetomigrationalone(27).
1126
28NOVEMBER2014 VOL346ISSUE6213
stimuliinvivo,OT-I/Il2ra+/+andOT-I/Il2ra / CD8+Tcellswerecotransferredintomiceinfectedwitheitherhigh-affinity(HKx31-N4)orlow-affinity(HKx31-Q4)influenzavirus(20).TheCytonmodelwasfittedtoTcellnumberstoestimatethein-creaseinDDduetoTCRaffinityorIL-2signalingalone(Fig.4,DandE,top,andtableS6).BysummationoftheseindividualcontributionstothemeanandvarianceoftheDDdistribution,wepredictedtheeffectofacombinedincreaseinTCRaffinityandIL-2signalingonDD(Fig.4E,bottom)andsuccessfullyrecreatedtheexpansionkineticsofOT-I/Il2ra+/+CD8+TcellsduringanHKx31-N4infection(Fig.4F).
ManipulatingTcellresponsesbycostimulationandcytokinesignalingisanimportantemergingtherapeuticregimen(28,29),andaquantitativeframeworkwillfacilitatetherationaldevelop-mentofoptimalinterventions.Tosupportthisgoal,weproposeaquantitativeparadigmwherenoonesignalisobligatorybutrathercombina-tionsofinputsaddtogethertogeometricallyen-hanceoutcomes(Fig.1A).Thus,combinationsofdifferentcostimulatoryandcytokinesignalspro-videmanyalternativepathstogenerateTcellresponsesofsimilarmagnitude.Thisframeworkreconcileslong-standingdiscrepanciesbetweeninvivoandinvitroresultsforIL-2andcostim-ulatorysignalsandrevealsaquantitativebasisforcurrentswitch-inspiredtwo-andthree-signalmodelsofactivation.FurtherstudiesmeasuringsimultaneousdifferentiationchangestoeffectorandmemorystatesassociatedwithcelldivisionwouldcompletetheTcellcalculatingframeworkandfurtherenhanceourabilitytopredictthera-peuticstrategiesforimmunomodulation.
1.D.Zehn,S.Y.Lee,M.J.Bevan,Nature458,211–214
(2009).
2.S.M.Kaech,R.Ahmed,Nat.Immunol.2,415–422(2001).3.M.J.vanStipdonk,E.E.Lemmens,S.P.Schoenberger,
Nat.Immunol.2,423–429(2001).
4.E.M.Bertram,W.Dawicki,T.H.Watts,Semin.Immunol.16,
185–196(2004).
5.J.M.Curtsingeretal.,J.Immunol.162,3256–3262
(1999).
6.A.G.Baxter,P.D.Hodgkin,Nat.Rev.Immunol.2,439–446
(2002).
7.D.A.Cantrell,K.A.Smith,Science224,1312–1316(1984).8.L.A.Gravestein,J.D.Nieland,A.M.Kruisbeek,J.Borst,Int.
Immunol.7,551–557(1995).
9.F.A.Harding,J.G.McArthur,J.A.Gross,D.H.Raulet,
J.P.Allison,Nature356,607–609(1992).
10.T.R.Malek,Annu.Rev.Immunol.26,453–479(2008).11.A.Oxenius,U.Karrer,R.M.Zinkernagel,H.Hengartner,
J.Immunol.162,965–973(1999).
12.A.Shahinianetal.,Science261,609–612(1993).13.K.P.J.M.vanGisbergenetal.,Immunity35,97–108
(2011).
14.E.D.Hawkins,J.F.Markham,L.P.McGuinness,P.D.Hodgkin,
Proc.Natl.Acad.Sci.U.S.A.106,13457–13462(2009).15.E.D.Hawkins,M.L.Turner,M.R.Dowling,C.vanGend,
P.D.Hodgkin,Proc.Natl.Acad.Sci.U.S.A.104,5032–5037(2007).
16.M.L.Turner,E.D.Hawkins,P.D.Hodgkin,J.Immunol.181,
374–382(2008).
17.M.R.Dowlingetal.,Proc.Natl.Acad.Sci.U.S.A.111,
6377–6382(2014).
18.M.Tomuraetal.,PLOSONE8,e73801(2013).
19.Materialsandmethodsareavailableassupplementary
materialsonScienceOnline.
20.A.E.Dentonetal.,J.Immunol.187,5733–5744(2011).21.E.D.Hawkinsetal.,Nat.Commun.4,2406(2013).22.V.R.Buchholzetal.,Science340,630–635(2013).23.C.Gerlachetal.,Science340,635–639(2013).
24.M.Hommel,P.D.Hodgkin,J.Immunol.179,2250–2260
(2007).
25.E.K.Deenick,A.V.Gett,P.D.Hodgkin,J.Immunol.170,
4963–4972(2003).
26.BecauseOT-Idivisiontimesarerelativelyhomogeneous,a
division-baseddilutionmodelisdifficulttodistinguishfromamechanismwherethelossofdivisionmotivationceasesinall
sciencemag.orgSCIENCE
(tumor specific antigen, TSA) 肿瘤相关抗原 (Tumor associated antigen, TAA) 31 医学上重要的抗原六、异嗜性抗原(heterophil antigen )又称为Forssman antigen,...
的组分称之为凝集素.其后将血清中 抗体 这种具有特异性反应的组分称为抗体(antibody,Ab),而将能刺激 机体产生抗体的物质称为抗原(antigen,Ag),由此建立了抗原和...
(fragment of antigen binding,Fab) 可结晶片段(fragment crystallizable,Fc) 轻链+VH、CH1 CH2和CH3 F(ab’)2 胃蛋白酶 (pepsin) 2个F(ab)及铰链区 pFc...
血清中存在一种能中和毒素的部分: 抗毒素(抗体Antibody, Ab) 刺激机体产生抗体的物质: 抗原(Antigen,Ag) 6 当时认为:抗体就是γ球蛋白 (丙球),丙球就是抗体...
木瓜蛋白酶(Papain)(将重链于近氨基端切断) Fab段(fragment of antigen- binding,抗原结合片 段) Fab段可以与抗原结合,具有抗体的活性。 Fc段(fragment ...
College of Life Science ShanDong Normal University TD抗原和TI抗原的比较胸腺依赖性抗原 Thymus-dependent antigen TD 非胸腺依赖性抗原 Thymus-independent antigen ...
裂解片段: 裂解片段: 2个Fab段(fragment of antigen binding) Fab段 1个Fc段(fragment crystallizable) Fc段 燕京医学院 2.胃蛋白酶水解片段 链铰链区链间二硫...
www.sangon.com 4 抗原与抗体抗原(antigen, Ag):指凡能刺激机体免疫系统产生特异性免疫应答、 并能与相应的免疫应答产物如抗体和致敏淋巴细胞在体内外结合的物质...
多克隆抗体和单克隆抗体 Antigen 31 2 4 1 2 Adapted from Milstein (1980) Scientific American, Oct. p.58 3 4 1 m m m m Spleen cells Immunization ...
V2 抗原-抗体反应的特点一、抗原抗体反应及效应抗原抗体反应(antigen-antibody reaction)是指抗原与相 应抗体之间所发生的特异性结合反应。可发生于体内也可 发生于...
热门文档